These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35010372)

  • 1. Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches.
    Albutti A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in SARS-CoV-2 ORF8 Altered the Bonding Network With Interferon Regulatory Factor 3 to Evade Host Immune System.
    Rashid F; Suleman M; Shah A; Dzakah EE; Wang H; Chen S; Tang S
    Front Microbiol; 2021; 12():703145. PubMed ID: 34335535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
    Suleman M; Murshed A; Imran K; Khan A; Ali Z; Albekairi NA; Wei DQ; Yassine HM; Crovella S
    BMC Chem; 2024 May; 18(1):99. PubMed ID: 38734638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Acute Respiratory Syndrome Coronavirus 2 ORF8 Protein Inhibits Type I Interferon Production by Targeting HSP90B1 Signaling.
    Chen J; Lu Z; Yang X; Zhou Y; Gao J; Zhang S; Huang S; Cai J; Yu J; Zhao W; Zhang B
    Front Cell Infect Microbiol; 2022; 12():899546. PubMed ID: 35677655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system.
    Suleman M; Said A; Khan H; Rehman SU; Alshammari A; Crovella S; Yassine HM
    Front Immunol; 2023; 14():1266776. PubMed ID: 38283360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors.
    Selvaraj C; Dinesh DC; Pedone EM; Alothaim AS; Vijayakumar R; Rudhra O; Singh SK
    Brief Funct Genomics; 2023 Apr; 22(2):227-240. PubMed ID: 36827221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase
    Elkaeed EB; Alsfouk BA; Ibrahim TH; Arafa RK; Elkady H; Ibrahim IM; Eissa IH; Metwaly AM
    Antivir Ther; 2023 Oct; 28(5):13596535231199838. PubMed ID: 37669909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein.
    Moschovou K; Antoniou M; Chontzopoulou E; Papavasileiou KD; Melagraki G; Afantitis A; Mavromoustakos T
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells.
    Kim IJ; Lee YH; Khalid MM; Chen IP; Zhang Y; Ott M; Verdin E
    J Biol Chem; 2023 Aug; 299(8):104955. PubMed ID: 37354973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell.
    Karkashan A; Attar R
    J Biomol Struct Dyn; 2023 Nov; 41(19):9987-9996. PubMed ID: 36437796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
    Tan Y; Schneider T; Leong M; Aravind L; Zhang D
    mBio; 2020 May; 11(3):. PubMed ID: 32471829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions.
    Vinjamuri S; Li L; Bouvier M
    Front Immunol; 2022; 13():1035559. PubMed ID: 36353628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
    Pal D; Checker R; Kutala VK; Sandur SK
    Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.
    Alshawaf E; Hammad MM; Marafie SK; Ali H; Al-Mulla F; Abubaker J; Mohammad A
    Microb Pathog; 2022 Sep; 170():105701. PubMed ID: 35963279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.
    Neches RY; Kyrpides NC; Ouzounis CA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of SARS-CoV-2 interaction with host (NRP1) neuropilin-1 receptor through high-affinity marine natural compounds to curtail the infectivity: A structural-dynamics data.
    Humayun F; Khan A; Ahmad S; Yuchen W; Wei G; Nizam-Uddin N; Hussain Z; Khan W; Zaman N; Rizwan M; Waseem M; Wei DQ
    Comput Biol Med; 2022 Feb; 141():104714. PubMed ID: 34772509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles and functions of SARS-CoV-2 proteins in host immune evasion.
    Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S
    Front Immunol; 2022; 13():940756. PubMed ID: 36003396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L; Wen Z; Song Y; Wang J; Yu D
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.